Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: A case-control study in Australia

Archives of Dermatology

Volumn 148, Issue 2, 2012, Pages 164-170

  Kvaskoff, Marina ^a,b   Siskind, Victor ^c   Green, Adèle C ^c,d  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INVASION; COMMUNITY; COMPARATIVE STUDY; DEPTH OF TAN; ENVIRONMENTAL FACTOR; EYE COLOR; FAMILY HISTORY; FEMALE; HAIR COLOR; HUMAN; LENTIGO; LENTIGO MALIGNA MELANOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SKIN COLOR; SKIN DEFECT; SOLAR LENTIGINES; SUN EXPOSURE; SUNBURN; SUPERFICIAL SPREADING MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; NEVUS; ODDS RATIO; PHENOTYPE; QUEENSLAND; RISK FACTORS; SKIN NEOPLASMS; SUNBURN; SUNLIGHT; YOUNG ADULT;

EID: 84857424471     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.291     Document Type: Article

References (31)

1. Duncan LM. The classification of cutaneous melanoma. Hematol Oncol Clin North Am. 2009;23(3):501-513, ix.
2. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1995;33(6):923-940.
3. Smalberger GJ, Siegel DM, Khachemoune A. Lentigo maligna. Dermatol Ther. 2008;21(6):439-446.
4. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol. 2005;125(4):685-691.
5. McGovern VJ, Shaw HM, Milton GW, Farago GA. Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology. 1980;4(3):235-242. (Pubitemid 10062979)
6. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95(11):806-812. (Pubitemid 36798427)
7. Green A, Little JH, Weedon D. The diagnosis of Hutchinson's melanotic freckle (lentigo maligna) in Queensland. Pathology. 1983;15(1):33-35. (Pubitemid 13185326)
8. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 2000.
9. Caini S, Gandini S, Sera F, et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer. 2009;45(17):3054-3063.
10. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst. 1987;78(1):37-44. (Pubitemid 17009768)
11. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women, II: phenotypic characteristics and other host-related factors. Am J Epidemiol. 1995;141(10):934-942.
12. Langholz B, Richardson J, Rappaport E, Waisman J, Cockburn M, Mack T. Skin characteristics and risk of superficial spreading and nodular melanoma (United States). Cancer Causes Control. 2000;11(8):741-750.
13. Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N. Clinical and histopathological characteristics in relation to aetiological risk factors in cutaneous melanoma: a population-based study. Melanoma Res. 1999;9(2):189-197. (Pubitemid 29331528)
14. Osterlind A, Tucker MA, Hou-Jensen K, Stone BJ, Engholm G, Jensen OM. The Danish case-control study of cutaneous malignant melanoma, I: importance of host factors. Int J Cancer. 1988;42(2):200-206.
15. Weiss J, Bertz J, Jung EG. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes. Dermatologica. 1991; 183(2):109-113.
16. Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma: an analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control. 2005;16(8):893-899. (Pubitemid 41191415)
17. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984;72(2):257-266. (Pubitemid 14156503)
18. Bastiaens M, ter Huurne J, Gruis N, et al. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet. 2001;10(16):1701-1708. (Pubitemid 32776300)
19. Debniak T, Scott R, Masojc B, et al. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer. 2006;119 (11):2597-2602. (Pubitemid 44691313)
20. Gaudy-Marqueste C, Madjlessi N, Guillot B, Avril MF, Grob JJ. Risk factors in elderly people for lentigo maligna compared with other melanomas: a double case-control study. Arch Dermatol. 2009;145(4):418-423.
21. Ródenas JM, Delgado-Rodríguez M, Farinas-Alvarez C, Herranz MT, Serrano S. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain. Am J Epidemiol. 1997;145(11):1020-1029. (Pubitemid 27215485)
22. Swerdlow AJ, Green A. Melanocytic naevi and melanoma: an epidemiological perspective. Br J Dermatol. 1987;117(2):137-146. (Pubitemid 17128466)
23. Auslender S, Barzilai A, Goldberg I, Kopolovic J, Trau H. Lentigo maligna and superficial spreading melanoma are different in their in situ phase: an immunohistochemical study. Hum Pathol. 2002;33(10):1001-1005. (Pubitemid 35215844)
24. Lee EY, Williamson R, Watt P, Hughes MC, Green AC, Whiteman DC. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis. Int J Cancer. 2006;119(3):636-642. (Pubitemid 43955718)
25. Holman CD, Armstrong BK, Heenan PJ. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst. 1983;71 (4):651-656. (Pubitemid 14232376)
26. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986;76(3): 403-414. (Pubitemid 16119774)
27. Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol. 1999;28(3):418-427. (Pubitemid 29276699)
28. Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst. 1984;73(1):75-82. (Pubitemid 14090830)
29. Bastiaens M, Hoefnagel J, Westendorp R, Vermeer BJ, Bouwes Bavinck JN. Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell Res. 2004;17(3):225-229. (Pubitemid 38724552)
30. Monestier S, Gaudy C, Gouvernet J, Richard MA, Grob JJ. Multiple senile lentigos of the face, a skin ageing pattern resulting from a life excess of intermittent sun exposure in dark-skinned caucasians: a case-control study. Br J Dermatol. 2006;154(3):438-444. (Pubitemid 43382649)
31. Dalton SR, Gardner TL, Libow LF, Elston DM. Contiguous lesions in lentigo maligna. J Am Acad Dermatol. 2005;52(5):859-862. (Pubitemid 40614652)